LEVOFAR is a pharmaceutical injectable formulation containing Levosulpiride at a concentration of 12.5 mg/ml. It is presented in a 2 ml ampoule format, with five ampoules supplied in each pack.
Levosulpiride belongs to the substituted benzamide class of compounds and exhibits dopamine D2 receptor antagonist activity. Its pharmacological properties are associated with dopaminergic pathways and gastrointestinal motility.
Product Composition
Each ml contains Levosulpiride 12.5 mg.
Formulation Details
Brand Name: LEVOFAR
Generic Name: Levosulpiride
Strength: 12.5 mg/ml
Dosage Form: Injection
Packing: 5 × 2 ml Ampoules
Route Mentioned on Pack: Intravenous (I.V.) / Intramuscular (I.M.)
Pharmacological Information
Levosulpiride acts primarily through dopamine D2 receptor antagonism. Its pharmacological activity is relevant to gastrointestinal motility and certain neurological pathways.
Important Information
LEVOFAR is a prescription injectable formulation. Administration, dosage and route selection must be determined by a qualified healthcare professional in accordance with approved prescribing information.
The product should be used only under appropriate medical supervision.
×
Send Enquiry
ISO, WHO And GMP Certified
(For Pharma Franchise & Third Party)